Cannamore Biotechs

An Israel-based clinical-stage company focused on Cannabidiol (CBD) based treatments.

Health Tech & Life Sciences
Active
Pre-Funding Bnei Brak, Israel Founded 2018
Last updated 2026-07-20
Total raised
Stage
Pre-Funding
Founded
2018
Headcount
2
HQ
Bnei Brak, Israel
Sector
Health Tech & Life Sciences

About

CannaMore Biotechs Ltd. is an Israel-based clinical-stage company dedicated to the independent research and development of cannabinoid-based pharmaceutical drugs for various indications. They leverage cutting-edge research through a partnership with Mor Research Applications, the technology transfer company of Clalit Health Services. CannaMore operates as a clinical research platform with multiple projects, with IcBD in colitis as their leading flagship.

Headcount over time

From 7 (2021-11) to 2 (2023-02) · -5 (-71%) · 5 points · source: Finder history + radar grounding
70 2021-11 2023-02

Q&A

What is Cannamore Biotechs' primary focus?
Cannamore Biotechs is a preclinical- and clinical-stage research platform company focused on developing novel and improved cannabis-based treatment options. The company is specifically developing a CBD-based solution for bronchiolitis obliterans, peripheral neuropathy, and inflammatory bowel diseases.
When was Cannamore Biotechs founded?
Cannamore Biotechs was founded in October 2018.
Where is Cannamore Biotechs headquartered?
Cannamore Biotechs is headquartered in Bnei Brak, Center District, Israel.
What is the current employee count for Cannamore Biotechs?
Cannamore Biotechs has 1-10 employees.
Who is the CEO of Cannamore Biotechs?
David Bassa is the CEO and a founder of Cannamore Biotechs.
What is Cannamore Biotechs' current funding stage?
Cannamore Biotechs is currently in the Pre-Funding stage.
Which sector does Cannamore Biotechs primarily operate in?
Cannamore Biotechs primarily operates in the Health Tech & Life Sciences sector, with additional focus on Pharma & Medical Biotechnology and Medical Cannabis.
What is the product stage of Cannamore Biotechs' solutions?
Cannamore Biotechs' products are in the clinical trial stage.

Team · 1

David Bassa
Founder · CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrugs Discovery & Development
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsHealthcareLaboratories
Business model
B2B

Tags

pharmaceuticalsbiopharmaceuticaltreatmentsinflammatory-diseasesmedical-cannabispharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitecannamorebio.com
LinkedInlinkedin.com/company/42950635

Identifiers & details

Legal nameCannaMore Biotechs Ltd.
Founded2018-10
Employees (exact)2

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domaincannamorebio.com

Certificate / subdomain footprint

Subdomains8

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515915916
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2018-10-22
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events1 — annual_report (1)
Registered addressבר כוכבא 23 בני ברק

Recent registry events

DateEvent
2026-01-26דו~ח שנתי